Search results
Results From The WOW.Com Content Network
A cholera vaccine is a vaccine that is effective at reducing the risk of contracting cholera. [10] The recommended cholera vaccines are administered orally to elicit local immune responses in the gut, where the intestinal cells produce antibodies against Vibrio cholerae, the bacteria responsible for the illness. This immune response was poorly ...
Turkey is a democratic, secular, unitary, constitutional republic with a diverse cultural heritage. [1] [2] As of July 2024, there are 2.439,859 registered companies based in the country. [3] The country has an emerging market economy as defined by the IMF. [4] Turkey is among the world's developed countries according to the CIA World Factbook. [5]
The Developing Countries Vaccine Manufacturers Network (DCVMN) is a voluntary non-partisan public health alliance of health organizations and vaccine manufacturers. It has the goal of protecting people globally against known and emerging infectious diseases through the provision of a consistent supply of high quality vaccines at affordable prices for developing countries, to achieve vaccine ...
The Turkish Medicines and Medical Devices Agency (TMMDA; Turkish: Türkiye İlaç ve Tıbbi Cihaz Kurumu) is a regulatory agency of the Government of Turkey that acts as the highest sanitary authority in terms of medical safety on medicines, health products, cosmetics and personal care products.
The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer ...
The WHO has prequalified three bivalent cholera vaccines—Dukoral (SBL Vaccines), containing a non-toxic B-subunit of cholera toxin and providing protection against V. cholerae O1; and two vaccines developed using the same transfer of technology—ShanChol (Shantha Biotec) and Euvichol (EuBiologics Co.), which have bivalent O1 and O139 oral ...
India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...
Cutter Laboratories was a family-owned pharmaceutical company located in Berkeley, California, founded by Edward Ahern Cutter in 1897.Cutter's early products included anthrax vaccine, hog cholera (swine fever) virus, and anti-hog cholera serum—and eventually a hog cholera vaccine.